SOS Jelly will evaluate the feasibility of the development, manufacturing method, technological transfer and industrial scale-up and to third parties manufacturers, and licensing for commercialization of a completely new biosynthetic molecule or mix of molecules, with bio-mimetic properties, for the first time, able to protect human skin from the jellyfish contact effects. Furthermore, ABICH laboratory will formulate creams and gel without preservatives at all, suitable for allergic people. At the end of the Phase I, a pre-commercial advanced SOS Jelly “package” (ingredient, formulation, laboratory test, regulation compliance, etc.) will be offered to manufacturers of sunscreen products. Target market is a high volume and growing market (millions of people, only in Europe).